Apontis Pharma - Solid results following a successful IPO

Following its successful IPO in May, Apontis’s maiden results highlight that the expansion of its single pill franchise continues at pace and should continue to provide high double-digit sales growth. These pills are combinations of commonly co-prescribed generic drugs that have been reformulated into one branded pill. [mehr]

Weiterlesen: https://ift.tt/3y8tD6d